Request Demo
Last update 27 Feb 2025
Matinas BioPharma Nanotechnologies, Inc.
Last update 27 Feb 2025
Overview
Tags
Nervous System Diseases
Other Diseases
Infectious Diseases
Small molecule drug
siRNA
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT05541107
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3
NCT04177680
Pharmacodynamic Effects of a Free-fatty Acid Formulation of Omega-3 Pentaenoic Acid to ENHANCE Efficacy in Adults With Hypertriglyceridemia: The ENHANCE-IT Trial
NCT03167957
A Single-Center, Open-Label, Pilot Study to Evaluate the Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis
100 Clinical Results associated with Matinas BioPharma Nanotechnologies, Inc.
Login to view more data
Login to view more data
19 Jul 2022Antimicrobial agents and chemotherapy
Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis
Article
Author: Hunsberger, Sally ; Swaim, Doris Z. ; Tramont, Edmund ; Freeman, Alexandra F. ; Mannino, Raphael ; Colton, Benjamin ; Stratton, Pamela ; Holland, Steven M. ; Urban, Amanda ; Ferrè, Elise M. N. ; Matkovits, Theresa ; Kibathi, Lilian W. ; Desai, Jigar V. ; Merideth, Melissa A. ; Lionakis, Michail S.
100 Deals associated with Matinas BioPharma Nanotechnologies, Inc.
Login to view more data
100 Translational Medicine associated with Matinas BioPharma Nanotechnologies, Inc.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 05 Mar 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Phase 3
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free